Volume 11, Number 7—July 2005
Perspective
Drug-resistant Neisseria gonorrhoeae in Michigan
Table 4
Prevalence of ciprofloxacin-resistant gonorrhea infection among surveillance population
% patients with QRNG (n/total) | Prevalence ratio (95% confidence interval) | p value | |
---|---|---|---|
Sex | 1.02 (1.00–1.04) | 0.03 | |
Male | 3 (19/697) | ||
Female | 1 (3/375) | ||
Men who have sex with men | 1.14 (1.05–1.24) | <0.0001 | |
Yes | 14 (12/87) | ||
No | 1 (7/488) | ||
White | 1.07 (1.02–1.11) | <0.0001 | |
Yes | 7 (13/178) | ||
No | 1 (9/896) | ||
Discharge and/or dysuria | 0.991 (0.960–1.02) | 0.57 | |
Yes | 2 (16/724) | ||
No | 3 (4/131) | ||
History of gonorrhea | 0.991 (0.967–1.02) | 0.52 | |
Yes | 2 (7/285) | ||
No | 3 (14/425) | ||
>40 y of age | 1.02 (0.975–1.06) | 0.30 | |
Yes | 4 (3/84) | ||
No | 2 (19/990) |